Company that worked on ArriveCan app banned from government contracts for 7 years
Ottawa says it has banned the largest contractor that worked on the ArriveCan app from entering into contracts or real property agreements with the government for seven years.
Public Services and Procurement Canada has announced that GC Strategies Inc. has been deemed 'ineligible' after an assessment of the supplier's conduct.
Last year, the department suspended the security status of GC Strategies, which the auditor general says was awarded more than $19 million for the project.
That move followed an earlier decision to suspend the company from procurement processes within the department. The government also barred two other companies that contributed to the ArriveCan project, Dalian Enterprises and Coradix Technology Consulting, from participating in procurement opportunities.
The federal government launched the app in April, 2020 as a way to track health and contact information for people entering Canada during the COVID-19 pandemic, as well as to digitize customs and immigration declarations.
A report by Canada's Auditor General Karen Hogan found the government's record-keeping was poor and its reliance on outside contractors allowed the cost of the project to balloon to $60 million.
The first ArriveCan contract was initially valued at just $2.35 million.
On Tuesday, Hogan is set to deliver an audit focusing on whether the contracts awarded and the payments made to GC Strategies and other incorporated companies were 'in accordance with applicable policy instruments' and were good value for money.
Public Services and Procurement Canada says the government continues to take action to 'strengthen the integrity of the procurement process.'
The Canadian Press has reached out to GC Strategies and to Public Services and Procurement Canada for comment.
GC Strategies partner Kristian Firth was ordered to appear before the bar of the House of Commons last year after refusing to answer questions at a committee hearing.
Firth was grilled by MPs for two hours, though Liberals opted out of questioning after a doctor's note provided to the clerk of the House recommended that he not appear because of mental-health issues.
GC Strategies did not develop or manage the ArriveCan app, but it was tasked by the federal government to assemble a team to complete some parts of the project.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
40 minutes ago
- CTV News
Trump warns Musk not to fund democratic candidates as feud continues
Trump warns Musk not to fund democratic candidates as feud continues CTV's U.S. Political Analyst Eric Ham on the 'mudslinging' feud between Donald Trump and Elon Musk and the warning for Musk not to fund democratic candidates.
CBC
an hour ago
- CBC
Seasonique birth control pills from Teva Canada recalled due to extra yellow tablets
Social Sharing Health Canada issued a recall notice on Friday for some Seasonique birth control products due to some packages containing the correct blue-green pills coming with extraneous yellow tablets. The agency says the recall is for the 0.01-milligram ethinyl estradiol, 0.03-milligram ethiny lestradiol and 0.15-milligram levonorgestrel Seasonique pills made by Teva Canada. Health Canada said those who find the yellow pills should not consume them and return the product to a pharmacy for a replacement or alternative, adding that those who can't return them right away should continue taking the regular blue-green tablets as instructed until they are able to return them. "If you took a yellow pill instead of a blue-green pill ... or if you are unsure, you should also use another method of non-hormonal back-up contraception (such as condoms) and consult with your health care professional," the agency said. Friday's contraceptive pill recall is the latest by Teva Canada. On Thursday, it recalled its Seasonale pills (0.15-milligram levonorgestrel and 0.03-milligram ethinyl estradiol) due to white placebo pills being found among the regular pink tablets. And in May, Teva Canada had to recall the same Seasonique tablets recalled on Friday due complaints that packages were missing some pills.
CBC
an hour ago
- CBC
Health authority interim CEO calls for further integration of AI into health care
Social Sharing Nova Scotia needs to merge artificial intelligence into the health-care system by way of a research centre, says the interim CEO of the Nova Scotia Health Authority. At a panel discussion on Friday at the Halifax Chamber of Commerce, Karen Oldfield said AI has been introduced to the health-care system in small amounts, but more needs to be done. "We have to lay this foundation," Oldfield said. "But to get to the predictive analytics, to wellness, to precision medicine, we have to have this." Oldfield says that the next logical step for the province is to develop a centre of excellence, meaning a hub dedicated to overseeing and researching AI. Oldfield expanded on this, saying AI would improve clinical efficiency and administration. Oldfield said AI could be used to determine a population or community with a higher likelihood of contracting diseases, like certain kinds of cancer. "If we can predict, then we can get ahead of it," said Oldfield. "That's really where most provinces and most countries want to get.... That's where we need to head." Oldfield says the development of such a centre would be dependent on people more than money. "We need the researchers that are able to use that data …to develop their algorithms that can lead us to predictive analytics and precision medicine," said Oldfield. The proposed AI centre for excellence is only in its early stages. Oldfield says she has had conversations about a centre with the Atlantic Canada Opportunities Agency and various members of the federal government.
